REVLIMID® (lenalidomide) logo

This site is intended for US audiences only.

This site is intended for US audiences only.

REVLIMID® (lenalidomide) is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells). REVLIMID should not be used to treat people who have chronic lymphocytic leukemia (CLL) unless they are participants in a controlled clinical trial. It is not known if REVLIMID is safe and effective in children.

Back to Top

The REMS Companion App

Easily access the
Lenalidomide REMS program.

Download now

Every patient with multiple
myeloma has a different journey

Allan, a former REVLIMID® (lenalidomide) patient with multiple myeloma
Blood cells
Blood cells

ABOUT MULTIPLE MYELOMA

Multiple myeloma is a blood cancer that affects the plasma cells in your blood.

ABOUT MM

multiple myeloma journey

There is no cure for multiple myeloma, but a treatment strategy may help you manage it.

Talk to your doctor about an appropriate treatment plan.

Learn More
Hypothetical REVLIMID® (lenalidomide) patient with multiple myeloma
Hypothetical REVLIMID® (lenalidomide) patient with multiple myeloma
Julie, a former REVLIMID® (lenalidomide) patient with multiple myeloma
Julie, a former REVLIMID® (lenalidomide) patient with multiple myeloma

patient stories

Hear patients talk about living with multiple myeloma.

Watch their stories
Hypothetical REVLIMID® (lenalidomide) patient with multiple myeloma standing outdoors and the My Moments, My Support logo

My Moments, My Support

My Moments, My Support is a program for patients and caregivers who want to learn more about taking REVLIMID for multiple myeloma.

GET INVOLVED
Hypothetical REVLIMID® (lenalidomide) patient with multiple myeloma and a caregiver holding hands while smiling

Caregiver support

Get more information about caring for your loved one with multiple myeloma, and for yourself.

Explore